Commentary

Article

State of the Science Summit - Hematologic Malignancies: Chaired by Veronika Bachanova, MD, PhD, and Jeffrey Miller, MD

State of the Science Summit - Hematologic Malignancies: Chaired by Veronika Bachanova, MD, PhD, and Jeffrey Miller, MD

State of the Science Summit - Hematologic Malignancies: Chaired by Veronika Bachanova, MD, PhD, and Jeffrey Miller, MD

Speakers

  • Jeremy Allred, MD | Masonic Cancer Center
  • Joseph Maakaron, MD | Masonic Cancer Center
  • Marie Hu, MD | Masonic Cancer Center
  • Craig Eckfeldt, MD, PhD | Masonic Cancer Center
  • Daniel O'Leary, MD | Masonic Cancer Center
  • Mark Juckett, MD, MHCM | Masonic Cancer Center
  • Sanjal Desai, MD | Masonic Cancer Center

Topics

  • Current and Emerging Treatment Standards for Myelodysplastic Syndrome
  • Debate! Bispecific Antibodies vs CAR T in R/R DLBCL
  • Treatment Crossroads: How do you sequence bispecifics and CAR T in Myeloma?
  • Emerging Agents in R/R AML
  • Sequencing Therapies in CLL

Interested in virtually attending an IPC event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science SummitsClick here to listen to our latest episodes!

Related Videos
DREAMM-7 update: Subgroup analyses from a phase 3 trial of belantamab mafodotin (belamaf) + bortezomib and dexamethasone (BVd) vs daratumumab, bortezomib, and dexamethasone (DVd) in relapsed/refractory multiple myeloma (RRMM)
Joseph Maakaron, MD, assistant professor, medicine, Division of Hematology, Oncology, and Transplantation, the University of Minnesota Medical School
Marie Hu, MD, assistant professor, medicine, Division of Hematology, Oncology and Transplantation, the University of Minnesota Medical School
Harry P. Erba, MD, PhD
Radhika Bansal, MBBS
Allison Winter, MD
Andrew Ip, MD
Eric Winer, MD
Monzr M. Al Malki, MD
Ibrahim T. Aldoss, MD; and Elias Jabbour, MD